Health
Regeneron suspends Covid-19 antibody trial among sickest patients – Macau Business
US biotech firm Regeneron on Friday said it was suspending enrollment for a study of its Covid-19 antibody treatment among the sickest patients
US biotech firm Regeneron on Friday said it was suspending enrollment for a study of its Covid-19 antibody treatment among the sickest patients who require high-flow oxygen or are on ventilators.
The move follows a recommendation from an independent data monitoring committee (IDMC) which assesses the results and advises when it’s necessary to halt a study.
“Based on a potential safety signal and an unfavorable risk/benefit profile at this time, the IDMC recommends further enrollment of patients…
-
Noosa News15 hours agoQueensland government looks to increase Spanish mackerel catch limits
-
Noosa News17 hours agoHow Queensland Premier David Crisafulli has gone from dazzling property flipper to secret business trouble
-
General9 hours agoInstagram’s new location-sharing feature is raising privacy concerns
-
Noosa News24 hours agoThe surprise Brisbane suburb ranked best for lifestyle buying